MF
BHVN

Magnetar Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Magnetar Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-363,372
Closed -$54.9M – 1528
2022
Q3 		$54.9M Sell
363,372
-227,844
-39% -$33.8M 0.76% 24
2022
Q2 		$86.1K Buy
+591,216
New +$75.5M 0.89% 21
2021
Q2 		– Sell
-10,231
Closed -$699K – 1527
2021
Q1 		$699K Buy
+10,231
New +$827K 0.01% 758
2019
Q3 		– Sell
-45,000
Closed -$1.97M – 638
2019
Q2 		$1.97M Buy
45,000
+39,476
+715% +$2.23M 0.04% 123
2019
Q1 		$284K Buy
+5,524
New +$239K 0.01% 325

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Magnetar Financial's BHVN Position: Q4 2022 in Review

Magnetar Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 363,372 shares — an estimated $54.9M sold.

Magnetar Financial first reported a position in BHVN in Q1 2019 and held it in 5 quarters. The position peaked at $54.9M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Magnetar Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Magnetar Financial sold 363,372 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $54.9M.
  • Magnetar Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 5 quarters.
  • Magnetar Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $54.9M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.